Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 7;39(12):185.
doi: 10.1007/s12032-022-01751-7.

Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence

Yinzhao Wang #  1 , Tailai Zhou #  1 , Hengxing Chen  1 , Sijie Wen  1 , Pinghong Dao  1 , Minfeng Chen  2
Affiliations

Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence

Yinzhao Wang et al. Med Oncol. .

Abstract

Bladder cancer (BCa) is the most prevalent cancer of the urinary system, but its pathogenesis is still poorly understood. Several reports have suggested that gene damage repair is highly correlated with tumor development and drug resistance, in which homologous recombination repair gene Rad54L seems to play an important role, through yet unclear mechanisms. Therefore, this study stratified cancer patients by Rad54L expression in BCa tissue, and high Rad54L expression was associated with a poor prognosis. Mechanistically, we demonstrate that high Rad54L expression promotes abnormal bladder tumor cell proliferation by changing the cell cycle and cell senescence. In addition, this study also suggests that Rad54L may be associated with p53, p21, and pRB in BCa tissue. In summary, this study exposes Rad54L as potential a prognostic biomarker and precision treatment target in BCa.

Keywords: Bladder cancer; Cell cycle; Rad54L; Senescence.

PubMed Disclaimer

References

Referencesig

    1. Globocan WHO. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon: WHO Globocan; 2012.
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. https://doi.org/10.3322/caac.21654 . - DOI - PubMed
    1. Chen X, Zhang J, Ruan W, Huang M, Wang C, Wang H, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020;130:6278–89. https://doi.org/10.1172/jci139597 . - DOI - PubMed - PMC
    1. Ruan W, Chen X, Huang M, Wang H, Chen J, Liang Z, et al. A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. Clin Epigenetics. 2021;13:91. https://doi.org/10.1186/s13148-021-01073-x . - DOI - PubMed - PMC
    1. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41. https://doi.org/10.1016/j.eururo.2012.07.033 . - DOI - PubMed

MeSH terms

LinkOut - more resources